ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 334

Use of Handheld Device to Enhance Patient Reported Outcome Measure Data Collection in an Academic Rheumatology Practice

Vivek Nagaraja1, Vladimir Ognenovski2 and Dinesh Khanna1, 1Division of Rheumatology, Department of Internal Medicine, University of Michigan Scleroderma Program, University of Michigan, Ann Arbor, MI, 2Department of Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, MI

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Electronic Health Record, patient outcomes and rheumatic disease

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Measures and Measurement of Healthcare Quality Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Patient-reported outcome measures (PROMs) are accepted modalities of gathering patient self-report of their health status in the realms of physical, mental and social well-being. PROMs are endorsed as metrics of quality of care. With the widespread implementation of electronic medical record (EMR) in the United States, PROM can be captured electronically. At the academic center, EMR in use is Epic® software which interfaces with the Patient-Reported Outcomes Measures System –PROMIS®. In a satellite clinic at UM rheumatology, the providers (n = 3) collectively opted to integrate PROMIS short from questionnaires [Adult Physical Function (PF) and Pain Intensity (PI)] into the EMR. However, the data collection of PROM via patient portals was low (5-10%). Our project aimed to examine collection rate of PROMs using portable devices (Tablets) at the time of check-in the clinic.

Methods: Between July 1, 2016, and March 31, 2018, patients seeking care at one rheumatology satellite clinic completed PROMIS® questionnaires (PF and PI), before the clinic visit. One week before the visit patients received a reminder on the EMR portal to complete the surveys. For patients who did not access questionnaire on the portal, they were able to complete at the time of appointment check-in on an Android-based Tablet. Those patients who could not complete by either portal or Tablet were assisted by a medical assistant (MA) using the office computer. The results were available on the EMR to the providers at the point of care.

Results: Of the total patients seen in rheumatology clinic, 87.2% completed the PROMIS® questionnaires, of which 82.4% used Tablets at check-in, 14.1% completed at home (portal), and 3.4% were assisted on a clinic desktop computer to complete the questionnaire (Table 1).

Conclusion: Use of tablets or other modalities in the clinic at check-in is associated with a high rate of PROMIS® questionnaire completion by patients. The routine use of PROM data collection at check-in may encourage patients to complete PROMIS® questionnaires on EMR portal accessed at home. Around 13% of patients did not complete questionnaires due to various reasons – lack of portal access, limited tablet availability at check-in, time constraints for MAs in a busy clinic, and rarely, patient refusal to complete. Given the increased acceptance, the routine of PROM data in the clinic using a tablet with EMR integration should be explored as a preferred modality.

Table 1: PROMIS® questionnaire completion rates

Quarter (year)

Total patients seen

Completed Questionnaires

Total N

Total %

At Home

In Office

Home Portal N

Home Portal %

Tablet N

Tablet %

Assisted by medical assistant

N

Assisted by medical assistant

N

Q3 (2016)

1127

941

83.5

83

8.8

817

86.8

41

4.3

Q4 (2016)

868

705

81.2

81

11.5

590

83.7

34

4.8

Q1 (2017)

866

825

95.3

104

12.6

708

85.8

13

1.6

Q2 (2017)

613

541

88.2

80

14.8

436

80.6

25

4.6

Q3 (2017)

764

656

85.9

112

17

532

81.1

12

1.8

Q4 (2017)

777

687

88.4

122

17.8

545

79.3

20

2.9

Q1 (2018)

747

671

89.8

130

19.4

514

76.6

27

4

Net

5762

5026

87.2

712

14.1

4142

82.4

172

3.4


Disclosure: V. Nagaraja, None; V. Ognenovski, None; D. Khanna, None.

To cite this abstract in AMA style:

Nagaraja V, Ognenovski V, Khanna D. Use of Handheld Device to Enhance Patient Reported Outcome Measure Data Collection in an Academic Rheumatology Practice [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/use-of-handheld-device-to-enhance-patient-reported-outcome-measure-data-collection-in-an-academic-rheumatology-practice/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/use-of-handheld-device-to-enhance-patient-reported-outcome-measure-data-collection-in-an-academic-rheumatology-practice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology